Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this article, I discuss recent work by Pankhurst et al. They found that MAIT cells can serve as a cellular adjuvant to boost immunity to a protein adjuvant. Intranasal co-administration of protein antigen with a strong MAIT cell ligand results in the the production of mucosal IgA and IgG antibody responses. This process is driven by MAIT cell-mediated maturation of migratory dendritic cells.

Original publication

DOI

10.1111/imcb.12648

Type

Journal article

Journal

Immunology and cell biology

Publication Date

07/2023

Volume

101

Pages

470 - 472

Addresses

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Keywords

Adjuvants, Immunologic, Administration, Intranasal, Antibody Formation, Immunity, Cellular, Immunity, Mucosal, Immunity, Humoral, Mucosal-Associated Invariant T Cells